| Catalog Merck # | USP Reference Standards Catalog Last Updated On: March 10, 2016 | Special Restriction |
|---|
| USPH1012906 | Alfentanil Hydrochloride CII (500 mg) | Material sujeto a control por el ISP |
| USPH1014005 | Alphaprodine Hydrochloride CII (250 mg) | Material sujeto a control por el ISP |
| USPH1015008 | Alprazolam CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1030001 | Amobarbital CII (200 mg) | Material sujeto a control por el ISP |
| USPH1036008 | Anileridine Hydrochloride CII (250 mg) | Material sujeto a control por el ISP |
| USPH1050905 | Benzaldehyde (3 X 1 mL) (List Chemical) | Precursor |
| USPH1059003 | Benzphetamine Hydrochloride CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1076465 | Bromazepam CIV (100 mg) (AS) | Material sujeto a control por el ISP |
| USPH1078700 | Buprenorphine Hydrochloride CIII (50 mg) | Material sujeto a control por el ISP |
| USPH1078711 | Buprenorphine Related Compound A CII (25 mg) ((S)-2-[17-(But-3-en-1-yl)-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl]- 3,3-dimethylbutan-2-ol) | Material sujeto a control por el ISP |
| USPH1079000 | Butabarbital CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1081002 | Butalbital CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1082504 | Butorphanol Tartrate CIV (350 mg) | Material sujeto a control por el ISP |
| USPH1096600 | Carisoprodol CIV (1 g) | Material sujeto a control por el ISP |
| USPH1096804 | Cathinone Hydrochloride CI (50 mg) (alpha-Aminopropiophenone Hydrochloride) | Material sujeto a control por el ISP |
| USPH1109000 | Chlordiazepoxide CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1110009 | Chlordiazepoxide Hydrochloride CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1140305 | Clonazepam CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1140509 | Clorazepate Dipotassium CIV (125 mg) | Material sujeto a control por el ISP |
| USPH1143008 | Cocaine Hydrochloride CII (250 mg) | Material sujeto a control por el ISP |
| USPH1143802 | Codeine N-Oxide CI (30 mg) | Material sujeto a control por el ISP |
| USPH1144000 | Codeine Phosphate CII (100 mg) | Material sujeto a control por el ISP |
| USPH1145003 | Codeine Sulfate CII (250 mg) | Material sujeto a control por el ISP |
| USPH1145025 | Codeine System Suitability Mixture CI (25 mg) | Material sujeto a control por el ISP |
| USPH1180004 | Dextroamphetamine Sulfate CII (500 mg) | Material sujeto a control por el ISP |
| USPH1180026 | Dextroamphetamine Related Compound B CII (25 mg) (Phenyl acetone) | Material sujeto a control por el ISP |
| USPH1183002 | Diacetylmorphine Hydrochloride CI (25 mg) (AS) (Heroin Hydrochloride) | Material sujeto a control por el ISP |
| USPH1185008 | Diazepam CIV (100 mg) | Material sujeto a control por el ISP |
| USPH1187207 | Dichloralphenazone CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1194009 | Diethylpropion Hydrochloride CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1200804 | Dihydrocodeine Bitartrate CII (200 mg) | Material sujeto a control por el ISP |
| USPH1219008 | Diphenoxylate Hydrochloride CII (200 mg) | Material sujeto a control por el ISP |
| USPH1219019 | Diphenoxylate Related Compound A CI (25 mg) (1-(3-Cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid) | Material sujeto a control por el ISP |
| USPH1235999 | Ephedrine Hydrochloride (List Chemical) (200 mg) | Precursor |
| USPH1236007 | Ephedrine Sulfate (200 mg) (List Chemical) | Precursor |
| USPH1240004 | Ergonovine Maleate (100 mg) (List Chemical) | Precursor |
| USPH1241506 | Ergotamine Tartrate (150 mg) (List Chemical) | Precursor |
| USPH1249905 | Estazolam CIV (100 mg) | Material sujeto a control por el ISP |
| USPH1255850 | Eszopiclone CIV (100 mg) | Material sujeto a control por el ISP |
| USPH1258305 | Ethchlorvynol CIV (0.7 mL) | Material sujeto a control por el ISP |
| USPH1269083 | Exemestane Related Compound C CIII (15 mg) (androsta-1,4-diene-3,17-dione) | Material sujeto a control por el ISP |
| USPH1269902 | Fentanyl CII (100 mg) | Material sujeto a control por el ISP |
| USPH1269957 | Fentanyl Related Compound E CII (10 mg) (N-Phenyl-1-(2-phenylethyl)-4-piperidinamine) | Material sujeto a control por el ISP |
| USPH1269979 | Fentanyl Related Compound G CI (10 mg) (Acetyl fentanyl; N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide) | Material sujeto a control por el ISP |
| USPH1270005 | Fentanyl Citrate CII (100 mg) | Material sujeto a control por el ISP |
| USPH1280009 | Fluoxymesterone CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1285002 | Flurazepam Hydrochloride CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1302305 | Halazepam CIV (200 mg) (AS) | Material sujeto a control por el ISP |
| USPH1307003 | Hexobarbital CIII (500 mg) | Material sujeto a control por el ISP |
| USPH1314960 | Hydrocodone CII (125 mg) | Material sujeto a control por el ISP |
| USPH1315001 | Hydrocodone Bitartrate CII (100 mg) | Material sujeto a control por el ISP |
| USPH1315012 | Hydrocodone Related Compound A CII (70 mg) (4-hydroxy-3-methoxy-17-methylmorphinan-6-one) | Material sujeto a control por el ISP |
| USPH1323000 | Hydromorphone Hydrochloride CII (50 mg) | Material sujeto a control por el ISP |
| USPH1323019 | Hydromorphone N-Oxide Hydrochloride CII (15 mg) | Material sujeto a control por el ISP |
| USPH1323021 | Hydromorphone Related Compound A CII (10 mg) (7,8-didehydro-4,5alpha-epoxy-3-hydroxy-17-methylmorphinan-6-one hydrochloride) | Material sujeto a control por el ISP |
| USPH1356009 | Ketamine Hydrochloride CIII (250 mg) | Material sujeto a control por el ISP |
| USPH1359506 | Levmetamfetamine CII (75 mg) | Material sujeto a control por el ISP |
| USPH1364007 | Levorphanol Tartrate CII (500 mg) | Material sujeto a control por el ISP |
| USPH1370305 | Lorazepam CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1371002 | Lysergic Acid Diethylamide Tartrate CI (10 mg) (AS) (LSD) | Material sujeto a control por el ISP |
| USPH1375309 | Mazindol CIV (350 mg) | Material sujeto a control por el ISP |
| USPH1383001 | Meperidine Hydrochloride CII (200 mg) | Material sujeto a control por el ISP |
| USPH1386000 | Mephobarbital CIV (250 mg) | Material sujeto a control por el ISP |
| USPH1389008 | Meprobamate CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1398009 | Methadone Hydrochloride CII (200 mg) | Material sujeto a control por el ISP |
| USPH1399001 | Methamphetamine Hydrochloride CII (125 mg) | Material sujeto a control por el ISP |
| USPH1405002 | Metharbital CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1413000 | Methohexital CIV (500 mg) | Material sujeto a control por el ISP |
| USPH1425000 | 4-Methyl-2,5-dimethoxyamphetamine Hydrochloride CI (25 mg) (AS) (STP) | Material sujeto a control por el ISP |
| USPH1429000 | Methylenedioxy-3,4-amphetamine Hydrochloride CI (25 mg) (AS) (MDA) | Material sujeto a control por el ISP |
| USPH1433008 | Methylphenidate Hydrochloride CII (125 mg) | Material sujeto a control por el ISP |
| USPH1434011 | Methylphenidate Hydrochloride Erythro Isomer Solution CII (0.5 mL) | Material sujeto a control por el ISP |
| USPH1438001 | Methyltestosterone CIII (250 mg) | Material sujeto a control por el ISP |
| USPH1443362 | Mibolerone CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1443599 | Midazolam CIV (300 mg) | Material sujeto a control por el ISP |
| USPH1443602 | Midazolam Hydrochloride CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1445404 | Modafinil CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1447002 | Morphine Monohydrate CII (50 mg) (AS) | Material sujeto a control por el ISP |
| USPH1448005 | Morphine Sulfate CII (500 mg) | Material sujeto a control por el ISP |
| USPH1448016 | Morphine Sulfate Related Compound A CI (20 mg) (Morphine N-Oxide) | Material sujeto a control por el ISP |
| USPH1448027 | Morphine Sulfate Related Compound B CII (20 mg) (Pseudomorphine) | Material sujeto a control por el ISP |
| USPH1452002 | Nalorphine Hydrochloride CIII (250 mg) | Material sujeto a control por el ISP |
| USPH1453526 | Naltrexone Related Compound A CII (30 mg) (N-(3-butenyl)-noroxymorphone Hydrochloride) | Material sujeto a control por el ISP |
| USPH1454008 | Nandrolone CIII (50 mg) | Material sujeto a control por el ISP |
| USPH1455000 | Nandrolone Decanoate CIII (250 mg) (COLD SHIPMENT REQUIRED) | Material sujeto a control por el ISP |
| USPH1456003 | Nandrolone Phenpropionate CIII (250 mg) | Material sujeto a control por el ISP |
| USPH1468400 | Nordazepam CIV (50 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one) | Material sujeto a control por el ISP |
| USPH1473002 | Noroxymorphone Hydrochloride CII (50 mg) | Material sujeto a control por el ISP |
| USPH1482003 | Oxandrolone CIII (50 mg) | Material sujeto a control por el ISP |
| USPH1482014 | Oxandrolone Related Compound A CIII (20 mg) (17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one) | Material sujeto a control por el ISP |
| USPH1482025 | Oxandrolone Related Compound B CIII (20 mg) (17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androsta-3-one) | Material sujeto a control por el ISP |
| USPH1482036 | Oxandrolone Related Compound C CIII (20 mg) (17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one) | Material sujeto a control por el ISP |
| USPH1483006 | Oxazepam CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1485191 | Oxycodone CII (200 mg) | Material sujeto a control por el ISP |
| USPH1485205 | Oxycodone Hydrochloride CII (1 g) | Material sujeto a control por el ISP |
| USPH1485216 | Oxycodone Related Compound A CII (10 mg) (14-hydroxycodeinone) (COLD SHIPMENT REQUIRED) | Material sujeto a control por el ISP |
| USPH1485227 | Oxycodone Related Compound B CII (15 mg) (oxycodone N-oxide) | Material sujeto a control por el ISP |
| USPH1485238 | Oxycodone Related Compound C CII (15 mg) (codeinone) | Material sujeto a control por el ISP |
| USPH1487007 | Oxymetholone CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1488000 | Oxymorphone CII (500 mg) | Material sujeto a control por el ISP |
| USPH1488019 | Oxymorphone Related Compound A CII (25 mg) (4,5alpha-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one N-oxide) | Material sujeto a control por el ISP |
| USPH1505007 | Pentazocine CIV (500 mg) | Material sujeto a control por el ISP |
| USPH1507002 | Pentobarbital CII (200 mg) | Material sujeto a control por el ISP |
| USPH1516003 | Phencyclidine Hydrochloride CII (25 mg) (AS) | Material sujeto a control por el ISP |
| USPH1516502 | Phendimetrazine Tartrate CIII (350 mg) | Material sujeto a control por el ISP |
| USPH1523009 | Phenmetrazine Hydrochloride CII (200 mg) | Material sujeto a control por el ISP |
| USPH1524001 | Phenobarbital CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1528501 | Phentermine Hydrochloride CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1533909 | Phenylpropanolamine Bitartrate (100 mg) (List Chemical) | Precursor |
| USPH1534005 | Phenylpropanolamine Hydrochloride (250 mg) (List Chemical) | Precursor |
| USPH1554501 | Prazepam CIV (500 mg) | Material sujeto a control por el ISP |
| USPH1574000 | Propoxyphene Hydrochloride CII (1 g) | Material sujeto a control por el ISP |
| USPH1575002 | Propoxyphene Napsylate CII (1 g) | Material sujeto a control por el ISP |
| USPH1581005 | Pseudoephedrine Hydrochloride (125 mg) (List Chemical) | Precursor |
| USPH1581504 | Pseudoephedrine Sulfate (200 mg) (List Chemical) | Precursor |
| USPH1592205 | Quazepam CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1611004 | Secobarbital CII (200 mg) | Material sujeto a control por el ISP |
| USPH1612845 | Sibutramine Hydrochloride CIV (125 mg) | Material sujeto a control por el ISP |
| USPH1620005 | Stanozolol CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1623648 | Sufentanil Citrate CII (25 mg) | Material sujeto a control por el ISP |
| USPH1643408 | Temazepam CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1645006 | Testolactone CIII (125 mg) | Material sujeto a control por el ISP |
| USPH1646009 | Testosterone CIII (125 mg) | Material sujeto a control por el ISP |
| USPH1646010 | Testosterone Related Compound A CIII (20 mg) (Androst-4-ene-3,17-dione) | Material sujeto a control por el ISP |
| USPH1647001 | Testosterone Cypionate CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1648004 | Testosterone Enanthate CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1649007 | Testosterone Propionate CIII (200 mg) | Material sujeto a control por el ISP |
| USPH1661002 | Thiopental CIII (250 mg) | Material sujeto a control por el ISP |
| USPH1672600 | Tramadol Hydrochloride CIV (100 mg) | Material sujeto a control por el ISP |
| USPH1672610 | Tramadol Related Compound A CIV (25 mg) ((+/-)-trans-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochloride) | Material sujeto a control por el ISP |
| USPH1673828 | Trenbolone Acetate CIII (200 mg) (COLD SHIPMENT REQUIRED) | Material sujeto a control por el ISP |
| USPH1673839 | Trenbolone Acetate System Suitability Mixture CIII (30 mg) (COLD SHIPMENT REQUIRED) | Material sujeto a control por el ISP |
| USPH1680506 | Triazolam CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1724350 | Zaleplon CIV (200 mg) | Material sujeto a control por el ISP |
| USPH1724893 | Zolpidem CIV (10 mg) | Material sujeto a control por el ISP |
| USPH1724907 | Zolpidem Tartrate CIV (200 mg) (COLD SHIPMENT REQUIRED) | Material sujeto a control por el ISP |
| USPH1724918 | Zolpidem Related Compound A CIV (15 mg) (N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide) | Material sujeto a control por el ISP |
| USPH1724951 | Zolpidem Impurities Mixture CIV (15 mg) | Material sujeto a control por el ISP |
| USPH1729118 | Zopiclone R-Isomer CIV (10 mg) ((-)-(5R)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate) | Material sujeto a control por el ISP |
